Rnc Capital Management Cut Gilead Sciences (GILD) Holding; Smtc (SMTX) Shorts Lowered By 15.54%

January 21, 2018 - By Kurt Siggers

Rnc Capital Management Llc decreased Gilead Sciences Inc (GILD) stake by 86.3% reported in 2017Q3 SEC filing. Rnc Capital Management Llc sold 72,231 shares as Gilead Sciences Inc (GILD)’s stock declined 8.05%. The Rnc Capital Management Llc holds 11,471 shares with $929,000 value, down from 83,702 last quarter. Gilead Sciences Inc now has $105.78 billion valuation. The stock decreased 0.23% or $0.19 during the last trading session, reaching $80.98. About 7.92M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since January 21, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Smtc Corporation (NASDAQ:SMTX) had a decrease of 15.54% in short interest. SMTX’s SI was 45,100 shares in January as released by FINRA. Its down 15.54% from 53,400 shares previously. With 19,900 avg volume, 2 days are for Smtc Corporation (NASDAQ:SMTX)’s short sellers to cover SMTX’s short positions. The SI to Smtc Corporation’s float is 0.36%. The stock increased 5.01% or $0.1034 during the last trading session, reaching $2.1684. About 62,222 shares traded or 116.99% up from the average. SMTC Corporation (NASDAQ:SMTX) has declined 18.75% since January 21, 2017 and is downtrending. It has underperformed by 35.45% the S&P500.

Since December 11, 2017, it had 3 buys, and 0 insider sales for $196,513 activity. 58,200 shares were bought by Waterfield John Randall, worth $95,448 on Tuesday, December 12. 27,917 shares were bought by Red Oak Partners – LLC, worth $44,321 on Monday, December 11.

SMTC Corporation provides electronics manufacturing services worldwide. The company has market cap of $36.48 million. The firm offers end-to-end electronics manufacturing services, including product design and engineering; printed circuit board assembly; production, enclosure, cable assembly, and precision metal fabrication; systems integration and testing; configuration to order; build to order; and direct order fulfillment services. It currently has negative earnings. It provides integrated contract manufacturing services to original equipment manufacturers and technology companies primarily in the industrial, networking and communications, power and energy, and medical market sectors.

Investors sentiment decreased to 0.2 in Q3 2017. Its down 0.55, from 0.75 in 2017Q2. It is negative, as 2 investors sold SMTC Corporation shares while 3 reduced holdings. 0 funds opened positions while 1 raised stakes. 2.07 million shares or 2.63% less from 2.12 million shares in 2017Q2 were reported. 3,882 were reported by Acadian Asset Lc. Nationwide Fund Advsrs reported 2,189 shares. Bridgeway Inc holds 0% or 170,000 shares. 10,000 are held by Fisher Asset Mngmt Lc. Wynnefield Cap owns 1.43 million shares or 0.67% of their US portfolio. Dimensional Fund Advisors Lp invested in 0% or 90,167 shares. Gilman Hill Asset Mngmt Ltd holds 15,977 shares or 0.01% of its portfolio. Ingalls & Snyder Llc reported 10,000 shares. Td Asset reported 50,535 shares. Renaissance Technologies Ltd Company accumulated 238,699 shares. California Public Employees Retirement Systems, California-based fund reported 25,860 shares.

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.10, from 0.93 in 2017Q2. It improved, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. Manufacturers Life Ins The has invested 0.53% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Wg Shaheen & Associates Dba Whitney & Company holds 0.94% or 39,465 shares in its portfolio. Sarl stated it has 0.28% in Gilead Sciences, Inc. (NASDAQ:GILD). British Columbia Investment owns 718,329 shares. Clear Harbor Asset Mngmt Limited Company reported 11,702 shares stake. Brandes Investment Prtn Limited Partnership stated it has 0.14% in Gilead Sciences, Inc. (NASDAQ:GILD). Stralem & Inc owns 12,100 shares. Garde Capital invested 0.13% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Quadrant Management Limited Company holds 22,546 shares or 1.35% of its portfolio. Cls Invests Ltd Limited Liability Company owns 74 shares for 0% of their portfolio. Nationwide Fund invested in 1.03M shares. 80,000 were accumulated by Sivik Glob Healthcare Limited Liability Co. Schroder Investment Management Group reported 3.64M shares. Lord Abbett Ltd Liability stated it has 0.01% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Krensavage Asset Mngmt Ltd Liability Corporation holds 520,924 shares.

Since August 1, 2017, it had 0 insider buys, and 12 sales for $43.50 million activity. MARTIN JOHN C sold $5.56 million worth of stock or 73,333 shares. On Tuesday, January 2 Alton Gregg H sold $1.11 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) or 15,000 shares. $4.99M worth of Gilead Sciences, Inc. (NASDAQ:GILD) was sold by Meyers James R. Shares for $4.40M were sold by Washington Robin L.

Rnc Capital Management Llc increased Adr stake by 9,315 shares to 476,484 valued at $28.87M in 2017Q3. It also upped General Mills Incorporated (NYSE:GIS) stake by 6,832 shares and now owns 565,541 shares. Phillips 66 (NYSE:PSX) was raised too.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on February, 6. They expect $1.67 earnings per share, down 36.74% or $0.97 from last year’s $2.64 per share. GILD’s profit will be $2.18B for 12.12 P/E if the $1.67 EPS becomes a reality. After $2.23 actual earnings per share reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -25.11% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: